Chemical modification of pseudo-dimannoside ligands guided by fragment-basedd esign allowed for the exploitation of an ammonium-binding region in the vicinity of the mannose-binding site of DC-SIGN, leading to the synthesis of ag lycomimetic antagonist (compound 16)o funprecedented affinity and selectivity against the related lectin langerin. Here, the computational design of pseudo-dimannoside derivatives as DC-SIGN ligands, their synthesis, their evaluation as DC-SIGNs elective antagonists, the biophysical characterization of the DC-SIGN/16 complex, and the structural basis for the ligand activity are presented. On the way to the characterization of this ligand, an unusual bridging interaction within the crystals shed light on the plasticity and potentials econdary bindings ites within the DC-SIGNc arbohydrate recognition domain.
Introduction
DC-SIGNi sat ransmembrane C-type lectin expressed at the surfaceo fd endritic cells. It plays ak ey role in the recognition of several pathogens and in the development of various infections, includingD engue andt he HIV virus. [1] Over the past decade, several glycomimetic ligandsh ave been designed to act as antagonists of DC-SIGNm ediated viral infections by using as template the pseudo-dimannoside (ps-diMan) scaffold 1 (Figure1A), composedo famannose ring connected to a conformationally locked cyclohexane diol. Chemical modifications of both the cyclohexanea ppendages and the 6-position of mannose, as in 2 and 3,l ed to improvements in the affinity of the ligands towards DC-SIGN-which remainsm odest (from a0 .9 mm IC 50 of 1 in SPR inhibition experiments to 0.3-0.2 mm for 2 and 3)b ut can be magnified by their polyvalent presentation. [2] Mosti mportantly,t hese structuralm odificationsa lso led to improved selectivity against the related C-type lectin langerin, which could be explained by comparatives tructural analysiso ft he two proteins. [3] In this work, we describe our efforts to improvet he affinity of the pseudo-dimannoside ligandsb yc omputationald esign, using af ragment-based screeningi nt he X-ray structure of DC-SIGN carbohydrate recognition domain (CRD) in complex with 1 (PDB 2XR5; PDB = Protein Data Bank). Thiss creening identified several moieties, predicted to bind to sites adjacent to the boundp seudo-dimannoside, and potentially amenable to modify its structures. Among them,w ef ocusedo nf ragments that favorably interacti nt he proximityo fP he313. This region, which is involved in binding several natural oligomannosides, [4] is near the 2-hydroxyl group of the mannoser ing (Man-O2)i n the DC-SIGN/ 1 complex( Figure 1B) . Pseudo-dimannoside structures could be therefore expanded at this positiona nd could, in principle, engage more productively with the protein, while remaining easily chemically accessible. The newly designed compounds derived from 1 were predicted to bind in the DC-SIGN CRDw ith favorable interactions. As opposed to screening of non-glycan small molecules, the presentapproach takes advantage of an aturals ugar elementt od irect the ligand to the CRD, thus avoiding off-target effects and interaction with other hot spots of the protein,w hich have been suggested to allosterically influence glycan binding. [5] Results and Discussion Fragment-based virtual screening and ligand design
To locate vicinal pockets as putative additional binding regions, we explored the surrounding of the pseudo-dimannoside binding site of DC-SIGN. Av irtuals creening (VS) of the Maybridge database (over one thousandd rug-like fragments, www.maybridge.com) wasp erformed by meanso fG lide using as startingp oint the crystallographic structure of DC-SIGN in complex with 1 (PDB 2XR5). Thec enter of the VS boxw as placed at the centroid among residues Phe313, Ser360 and Lys373,a nd wase xpandedb y1 0 in each x, y and z axis. A total of 50 fragments were selected (5 %b est docked fragments)f or visual inspection.M ost of the fragments were placed in the region enclosed by residues Asn344, Glu358, Ser360, Asn365, Asp367, Phe313,L eu371 and Lys373 (Figure 2A )a nd they all bore an ammonium moiety anda na romatic ring. The ammonium group was docked into an "ammonium-binding pocket" in close proximity to the Ca 2 + binding site and lined by Phe313, Glu358 and Ser360. Stabilizing interactions thus include ion pair with Glu358 side chain, hydrogen bond with Ser360s ide chain, and cation-p contactsw ith Phe313 phenyl ring ( Figure 2A ). Interestingly,t he ammoniumbinding pocket identified by virtuals creening corresponds to a region occupied by highly conserved water molecules in the known X-ray structures of DC-SIGN and its sugar complexes (PDB 2IT5, 2IT6, 2XR5, 1SL4 and 1K9I). The aromatic moiety of the fragments (either ap henylo rah eterocyclicr ing) was found docked close to Phe313,A sn344 and Leu371 side chains and established p-p or CH-p interactions with these residues. Other fragments were predicted to bind outside the ammonium-binding pocket, but were not prioritized for furtherd esign and synthesis.
Excitingly,the pose of the fragments docked into the ammonium-binding pocket clearly allowed for conjugation to the position 2o ft he mannose ring of ps-diMan 1,apositionw ith many opportunities for functionalization not completely exploited so far.A mong the possibilities explored, we focused on structures that can be easily accessible startingf rom the 2azido derivative of 1 (compound 4 in Scheme 1) and using Copper(I)-catalyzed AlkyneA zide Cycloaddition (CuAAC) reaction with a-aminoalkynes,t oa fford the amino triazoles 5 (Scheme 1). Thus, an umber of derivatives of general formula 5 were computationally built as putative ligands (including the S and R configurations;F igures 3a nd Figure S1 in the Supporting Information) and docked in the DC-SIGN CRD ( Figure 2B ), to predict their binding capability.T he detailso ft he calculations are reported in the Supporting Information.
The designed compounds were docked in three different DC-SIGNc onformations: two from the X-ray crystallographic structures 2XR5 and 2IT5 (differing in some side chains orientations of the residues close to the carbohydrate binding site, Figure S2 in the Supporting Information), and at hird one obtained as an average from the molecular dynamics (MD) simulation of apo DC-SIGN from PDB 2XR5, in which rotamers of Val351 were observed. All designed compounds were predicted to bind the CRD mannoside-binding site with the pseudodimannoside moiety bound in similar pose to that of 1 in the complex with DC-SIGN (PDB 2XR5). The triazole moietyh as optimal orientation to reach the ammonium-binding pocket and to allow the ammonium group to interact with Phe313 and Glu358 side chains (Figure2Ba nd FigureS3i nt he Supporting Information). On this basis, the synthesis of severalt riazole derivatives 5 was planned and executed as described below and selected DC-SIGN/5 complexes were also submitted to MD simulations (see below).
Synthesis
For the synthesis of the 2-azido pseudo-dimannoside 4,g lycosyl donor 9 was prepared in three steps starting from d-mannosamine hydrochloride 6 (Scheme 2). Compound 6 was converted into the corresponding azide 8 by diazotransfer with imidazole-1-sulfonyl azide hydrogensulfate 7, [6] as previously described forG lcNH 2 and GalNH 2 .A pplyingt he same reaction conditions to ManNH 2 6 initially led to poor yields andi rreproducible results. Alternative procedures for the preparation of 2deoxy-2-azidoMan derivatives have indeed been reported in the literature as producing manno-/gluco-m ixtures, in which the gluco-like impurities are often ascribed to contamination of the mannosamine startingm aterial. [7] We found that formation of the gluco-b y-product (GlcN3)d uring the diazotransfer is actually due to epimerization at position2,p romoted by the excess of potassium carbonate. Stepwise addition of K 2 CO 3 at low temperature (À20 8C) andc areful pH control allow to avoid epimerization andt oo btain reproducible high yields (90 %) of pure 1,3,4,6-tetra-O-acetyl-2-deoxy-2-azidoMan 8, from which the 2-deoxy-2-azidomannosyl donor 9 was obtained following established protocols. [8] The known acceptor 10 [3a] was glycosylated with 9 in the presence of ac atalytic amount of TMSOTf, affording the desired common intermediate 11 in 90 %o verall yield. Reaction of the azide 11 with alkynes through CuAAC [9] followed by ZemplØnd eprotection afforded the triazole derivatives 5 and 12-16 (Scheme 2a nd Figure 3 ), as detailed in the Supporting Information. The requireda lkynes were either commercially available, or prepared in af ew steps,a sd escribed in the Supporting Information (Figure S7 , Supporting Information). The synthesis of aryl-propargyl amines in enantiomericallyp ure form is not trivial. [10] For this preliminarys creening we prepared triazole 5d ( Figure 3 ) as an epimeric mixture at the Nbearing stereocenter by using the corresponding racemic propargyl amine (commercially available). The two isomers provedt ob ec hromatographically inseparable, just as the corresponding methyl derivatives 5c,a nd both molecules were tested as diastereomeric mixtures. On the contrary,t he benzyl alcohols 15 b ( Figure 3 ) synthesized as an epimeric mixture from (AE)-1-phenylpropynol could be separated chromatographically and were tested as individual isomers, although the configuration of the benzylic stereocenter was not assigned (15 b R/S and 15 b S/R in Figure 3 ). The 2-and 3-pyridyl derivatives 13 and 14 were synthesized from the corresponding commercially availablealkynes.
SPR competition assay
The compounds obtained were tested by surfacep lasmon resonance( SPR) as potentiali nhibitors of DC-SIGN interaction with an immobilized mannosylated bovine serum albumin (BSA). The IC 50 values obtained from the SPR inhibition assays for the triazole derivatives and their parentc ompounds 1-3 ( Figure 1A )a re plotted in Figure4Aa nd the corresponding valuesc ollected in Ta ble S1 (Supporting Information). In bearing with the computational predictions for the ammoniumbinding site, the methylenaminot riazole derivative 5a gave an IC 50 of 108 AE 1 mm,w ith one order of magnitude improvement over the parent ps-diMan 1.A ddition of methyl substituents on the a carbon of the triazole ring, as in 5b,c was detrimental for the affinity.S imilarly,a dditional methyl groups on the nitrogen atom, meant to stabilize the positive chargea si n12 a-c, led to as ignificant decrease in affinity.C ollectively,t hese data suggest an egative effect of steric hindrance at, or near to, the ammonium-binding site. Interestingly,l igand 15 a,i nw hich the amine is replaced by ah ydroxyl group, also provided at hreefold affinity improvemento ver 1 (IC 50 of 339 AE 7 mm)s uggesting ap ositive role of H-bonding ability in that position. Indeed, docking of 15 a yielded ap ose that placed the OH group into the ammonium-binding site (not shown). This result is also in agreement with the observation that the ammonium-binding site identified by VS overlaps with ah ighly conserved hydration sitei nt he DC-SIGN CRD crystals. The effect of aromatic substituents on the a carbon of the triazole ring was more difficult to dissect, because the epimericm ixture of a-phenyl derivatives 5d could not be separated.S PR analysiso ft he mixture yieldeda nI C 50 of 407 AE 7 mm (Figure 4A ), indicating af ourfold loss of activity relative to 5a. Luckily,t he corresponding epimeric alcohols 15 b R/S and 15 b S/R could be separated by flash chromatography and were tested separately in the inhibition experiment, yielding an IC 50 value of 870 AE 1 mm and5 90 AE 4 mm,r espectively.T hus, none of the epimers provided an improvement over the parenta lcohol 15 a.A lternatively,t he 2-pyridyltriazole 13, which does not feature ap ositive charge at the pH of the assay (pH 8), but presentst he pyridine nitrogen adjacent to the triazole ring, afforded an IC 50 180 AE 6 mm and, thus, av ery significant improvementover 1.This suggeststhat the pyridine moiety can be engaged in stabilizing( lipophilic) contactsw ith the protein surface. Docking calculations predict the pyridine ring to be involved in edge-to-face interactions with the Phe313 side chain andp ossibly in H-bonding interaction with Lys373.I ndeed, the position of the pyridine nitrogena ppears to playacrucial role, since the 3-pyridyl derivative 14,w ith an IC 50 609 AE 6 mm,s hows af ivefold loss of activity relative to 13. Overall,f unctionalization of the mannoser esidue with at riazole ring carrying ana mmonium group was found to increase the DC-SIGN affinity,a se xpected based on the computational models. So far,t he beneficial effects of an aromatic substituent have not been fully confirmed by the limited set of compounds synthesized and analyzed.
Based on the SPR results, 5a was chosen as lead compound for transformation into 16 ( Figure 3 ), which combines the backbone structure of 2 (carrying two p-hydroxymethylenebenzylamide substituents on the cyclohexane ring) and the functionalization of 5a at mannoseC -2. As mentioned above, 2 has an enhanced affinity towards DC-SIGN comparedt o1 (IC 50 = 329 mm and 956 mm for 2 and 1,r espectively) and is significantly more selectivea gainst langerin. [3a] Thus, this switch of scaffold was expected to improveb otha ffinity and selectivi-ty of the ammonium-carrying ligand. SPR binding inhibition studies were performed for 16 and DC-SIGN affording an IC 50 of 76 AE 3 mm ( Figure 4A ). Additionally, 5a, 13 and 16 were also tested against langerin:s electivity towards DC-SIGNi ncreased from 5a to 13 and reached am aximum with 16 ( Figure 4B ). Thus, 16 is the most effective ands elective mannose-based glycomimetic antagonist developed to date against DC-SIGN.
Biophysical characterization of 16 bindingtoD C-SIGN
To further characterize the bindingi nteraction of 16 with DC-SIGN, an ITC titration was performed. Ligand 16 (2.5 mm)w as titrated into aD C-SIGN solution (100 mm)( Figure S5 A, Supporting Information). Ao ne binding site model fitting of the data with an assumed stoichiometry value fixed to 1y ielded an equilibrium dissociation constant K D of 52.0 AE 1.3 mm,i na greement with the IC 50 determined by competitiona ssay (IC 50 76 AE 3 mm). The high affinity of 16 for DC-SIGN also allowed for the evaluation of the interaction in aS PR direct bindingm ode by using aD C-SIGNf unctionalized surface. [11] The resulting K Dapp from steady state fitting was found to be 52.7 AE 2.7 mm (Figure S5 B, Supporting Information) in good agreement with the results obtainedb yI TC. The ITC analysis yielded DH = À19.6 AE 0.2 kJ mol À1 and a TDS = 4.9 AE 0.2 kJ mol À1 ,l eading to a DG of À24.46 kJ mol À1 .T hus, 16 binding is mainly enthalpically driven,p otentially due to the additional interactions brought by the aminogroup added in 16.
X-ray crystallography
Co-crystallization experiments of DC-SIGN CRD and 16 were conducted. Crystals were obtaineda nd their structure was solved at 2.1 resolution (PDB 6GHV). The data revealed at otally new crystal packing, compared to previousD C-SIGN structures, with an asymmetric unit composed of six CRDs and six molecules of 16 ( Figure 5A ). This crystal packing( space group P12 1 1) is enabled by each ligand molecule reaching out to a second CRD unit, thus formingasymmetric network . Each ligand therefore bridges the canonical Ca 2 + binding site in one CRD and ac avity generatedb etween helix 2 and the following loop upstream of the b4s trand of the next CRD ( Figure 5C ). As expected, the Ca 2 + ion is coordinated by Man-O3a nd Man-O4,w hile the noncanonical site in the next CRD is occupied by one of the p-hydroxymethylenebenzylamide substituents of 16.I na ddition to these two main interactions sites, 16 is also in contact with an eighboring third CRD (the green chain in Figure 5B ), thanks to the second benzylamide arm. The binding mode of 16,d ue to the extended interaction with DC-SIGN CRDs in this packing, is very well defined,a llowing af ine analysisw ithin each different binding site ( Figure 5B ,C as well as Figures 6a nd 7) . Compared to the X-ray structure of DC-SIGN/ 1 complex, the two additional fragments of 16 that make contact with the protein, both the ammonium group and the intercalated benzylamidea rm, point to druggable secondary sites recently identified by Aretz et al. [12] ( Figure S6 , Supporting Information).
The noncanonicali nteraction site that determines the bridge between CRDs by 16 in the crystals is shown in Figure6.T he overlay of the backbones tructures of DC-SIGNC RD (PDB 1K9I, Figure 6 , pink) with the structure of our complex ( Figure 6 , cyano) shows ac onservation of structural elements, with the exceptiono fakink in helix 2. This helix movement results from the insertion of a p-hydroxymethylenebenzylamide arm between the helix and af acing loop ( Figure 6 ). BackboneC O group from Ser271 provides stabilizing H-bond with the benzylic hydroxy group of 16 through ab ridging water molecule ( Figure 6A ), whereas al arge movement of Arg312g enerates the required cavity (compare Figure 6B and C) and provides additional stabilization through H-bond with the amide carbonyl ( Figure 6A ). These structurala djustments for the p-hydroxymethylenebenzylamide arm illustratet he plasticityo ft he CRD backboneo fD C-SIGN as previously observed for langerin. [13] In the crystal, 16 interacts similarly to the previously characterizedb inding mode fort he glycomimetics 1-3 [3, 14] exploiting Val351 side chain for nonpolari nteractions with the cyclohexane ring. Here, for the first time, details of the interaction of the benzylamide arm with the primary CRD surface, previously suggested by NMR studies, are highlighted. Thus, the amide carbonyl is H-bonded to Lys368 in the CRD, the benzylr ing is in van der Waals contact with the loop containing Val351 and Gly352 and the terminal OH group is involved in aH -bonding network with the protein surface through two water molecules ( Figure 7A ). These results are in agreement with MD calculations of the complex, which anticipated one of the benzylamide arms to be dangling in the solvent( thus becoming availablef or the secondary interactions described above)a nd the second one oscillating CH-p interactions with Val351 and Gly352, whereas its terminal hydroxyl group alternates Hbonds with the backbone CO of Asn350, Gly352 NH and solvent water molecules ( Figure 7C and Figure S4 in the Supporting Information). The additional ammonium group,c onnected to mannose C-2 through at riazole linker,r eaches Ser360 and Glu358,a si nitially predicted from the docking analysis. Inter- Figure S4 , Supporting Information). In this posi-tion, ac ation-p interaction is also generatedw ith Phe313, as expected from the distance of 3.3 between the ammonium group and the phenyl ring ( Figure 7A ). The cumulative interactions resulting from the ammonium ion may account for the improved enthalpy contributiont ot he binding observed in the ITC studies described above.I nF igure 7B,t he CRD representation as electrostatic surfacep otentialh ighlightst he negative potential favoring ammonium binding.
Due to the peculiar position of 16 at the interface of three CRDs in the crystal packing, the relevance of the binding mode observed in the Ca 2 + binding site could be questioned. However,t he conservation of the binding mode observed with 1 and 2,f rom which 16 is derived, and the perfectc orrelation of the ammoniumg roup binding pocket with the computational prediction support the coherence of the complex structure observed. The question remains whether the unexpected bridging interaction observed in the crystal may also be present in solution and account for the improved affinity of 16 for DC-SIGN. Bridging of DC-SIGN tetramers by glycomimeticl igands in solution has been previously observed and characterized by analytical ultracentrifugation (AUC) with ap seudo-trimannoside compound. [15] Thus, to discriminate between acrystallization-induced artefact and ag enuine additional binding site in solution, AUC experiments were performed by using either DC-SIGNC RD ( Figure 8A ,c rystallization condition) or the full tetrameric extracellular domain (ECD, Figure 8B )a tf ixed concentration (56 and 26 mm,r espectively), while increasing the concentration of 16.For the CRD, the sedimentation coefficient remained unchanged to av alue around 1.8 S( s 20 w = 2.1 S), at all the used concentrations of 16,s howingt he absence of dimerization and, therefore, the absence of ac lustering effect of 16 towardsD C-SIGNC RD in solution,a so pposed to the crystal context. The same was found for DC-SIGN ECD, which sedimented as at etramera t4 .5 S( s 20 w = 5.4 S, close to the previously published), alonea nd in the presence of 16. [15, 16] From this last characterization, we can assume that only binding in the canonical Ca 2 + site exists in solution and is by itself responsible for the unprecedented affinity observed with this glycomimetic.
Conclusion
In summary,c hemical modification of the known glycomimetic ligand 1 guidedb yf ragment-based design allowed for the exploitation of an ammonium-bindingr egion in the vicinity of the sugar-binding site of DC-SIGN, improving by one order of magnitude the inhibitory potency. ITC confirmed that the novel antagonist 16,w ith a K D of 52 AE 1 mm,i sa mong the most potent monovalentD C-SIGNl igands so far described, [17] whereas SPR analysis showed that it is also fully selective for DC-SIGNv ersus langerin. The X-ray structure of the DC-SIGN/ 16 complex fully validated the modeling prediction and offered as tructuralb asis for the result interpretation. In particular,t he presence of an ammoniumi on in 16 contributes simultaneously to the high affinity for DC-SIGN, by interacting with an ammonium-binding region in the vicinity of Phe313, and to the selectivity for DC-SIGN vs. langerin, which harborsalargely positive binding site rich in lysine residues. [3b] AUC analysis convincingly confirmed that the affinity increase observed for 16 relative to previous pseudo-dimannoside-type ligandsi s not due to induced aggregation of soluble DC-SIGN CRD. Altogether,t hese features make 16,o riginated from af ragmentbased design approach, the best glycomimetic developed to date to efficiently target DC-SIGN. In addition, the intriguing features observed in the X-ray structure of the DC-SIGN/16 complexo ffer ag limpse of the plasticity of the receptor CRD, which is likely to be central to af ullu nderstanding of its machinery.
Experimental Section

Computational methods
Virtual screening was performed by using Glide and the Maybridge Ro3 core set fragment library.L igand docking was performed by using AutoDock 4a nd the MD simulations using AMBER14. The experimental details are reported in the Supporting Information.
Syntheses
General experimental conditions are reported in the Supporting information. 3-Azidosulfonyl-3H-imidazol-1-ium hydrogen sulfate 7 was synthesized as described in Ref.
[6b].T he alkynes used for the CuAAC reactions are collected in Figure S7 (Supporting Information). The synthesis of the non-commercially available alkynes and the full synthesis of 16 are described in the Supporting information.
1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-d-mannopyranose (8): d-Mannosamine hydrochloride (1.2050 g, 5.59 mmol, 1mol equiv) was suspended in dry MeOH (50 mL) and cooled to À20 8C. K 2 CO 3 (811mg, 5.87 mmol, 1.05 mol equiv) was dissolved in 4mLw ater and added to the stirred suspension. CuSO 4 *5H 2 O( 14 mg, 0.06 mmol, 0.01 mol equiv) was added to the mixture. Another portion of K 2 CO 3 (811mg, 5.87 mmol, 1.05 mol equiv) in 4mLw ater was added, immediately followed by the addition of imidazole-1sulfonyl azide (1.8190 g, 6.7080 mmol, 1.2 mol equiv). The pH was continuously controlled and the reaction was stirred at À20 8Cf or 2hours, when it was left to warm to RT (light-blue suspension). After 4hours, only one major spot was detected by TLC (R f = 0.4 in 8:2C H 2 Cl 2 /MeOH). The solvent was evaporated in vacuo and the crude was suspended in dry pyridine (20 mL) . The mixture was cooled to 0 8Ca nd Ac 2 O( 4.22 mL, 44.72 mmol, 8mol equiv) was added dropwise. The reaction was stirred overnight at RT and the next day only one major spot was detected on TLC (R f = 0.36 in toluene/EtOAc = 9:1). The crude was purified by flash chromatography (toluene/EtOAc = 9:1) to yield the pure product 8 as aw hite foam (1.9 g, 92 %), a/b = 2:1. a-anomer: 1 HNMR (400 MHz, CDCl 3 ): d = 6.09 (d, 1H,H 1 , J 1-2 = 1.9 Hz), 5. 43-5.34 (m, 2H,H 3 ,H 4 .6 (C=O( AcO));1 69.9 (C=O( AcO));1 69.3 (C=O (AcO));1 68.1 (C=O( AcO));9 1.7 (C 1 ); 71.1 (C 3 ); 71.1 (C 5 ); 65.6 (C 4 ); 62.1 (C 6 ); 60.1 (H 2 ); 21.2 (Me (OAc));2 0.9 (Me (OAc));2 0.9 (Me (OAc));20.8 ppm (Me (OAc)). Hz, J = 9.9 Hz), 2.18 (s, 3H, AcO), 2.11( s, 3H,A cO), 2.08 (s, 3H,A cO), 2.04 ppm (s, 3H,A cO). 13 CNMR (100 MHz, CDCl 3 ): d = 170.6 (C=O( AcO));1 69.9 (C=O (AcO));1 69.3 (C=O( AcO));1 68.1 (C=O( AcO));9 1.5 (C 1 ); 73.6 (C 5 ); 72.2 (C 3 ); 65.3 (C 4 ); 62.1 (C 6 ); 61.4 (H 2 ); 21.1 (Me (OAc));2 1.1 (Me (OAc));21.0 (Me (OAc));2 0.9 ppm (Me (OAc)).
3,4,6-Tri-O-acetyl-2-azido-2-deoxy-d-mannopyranose.1 ,3,4,6tetra-O-acetyl-2-azido-2-deoxy-D-mannopyranose 8 (506 mg, 1.36 mmol, 1mol equiv) was dissolved in 1mLd ry THF and cooled to 0 8C. 813 mL2m MeNH 2 in THF (1.63 mmol, 1.2 mol equiv) was added to the solution and the reaction was stirred at RT for 1.5 hours. After completion, the mixture was concentrated and the crude was purified by flash chromatography (R f :0 .27 (a)a nd 0.24 (b)i nt oluene/EtOAc = 6:4). The product was obtained in 97 %y ield (437 mg) as a8 7:13 a : b anomeric mixture. 1 HNMR (400 MHz, AcO) );1 70.0 (C=O( AcO));1 69.6 (C=O (AcO));9 2.8 (C 1 ); 70.7 (C 3 ); 68.6 (C 5 ); 65.9 (C 4 ); 62.2 (C 6 ); 61.7 (C 2 ); 20.8 (Me (OAc));2 0.7 (Me (OAc));2 0.6 (Me (OAc)). b-anomer: d = 170.8 (C=O( AcO));1 70.0 (C=O( AcO));1 69.6 (C=O( AcO));9 2.7 (C 1 ); 72.8 (C 3 ); 72.4 (C 5 ); 65.4 (C 4 ); 63.5 (C 2 ); 62.1 (C 6 ); 20.8 (Me (OAc)); 20.7 (Me (OAc));2 0.6 ppm (Me (OAc));M S( ESI): m/z calculated for [C 12 H 17 2-Azido-2-deoxy-3,4,6-tri-O-acetyl-d-mannose trichloroacetimidate (9):3 ,4,6-tri-O-acetyl-2-azido-2-deoxy-d-mannopyranose (400 mg, 1.20 mmol, 1mol equiv) was dissolved in 5mLC H 2 Cl 2 , cooled to 0 8Ca nd trichloroacetonitrile (1.33 mL, 13.29 mmol, 11 mol equiv) was added to the solution. Then, 1, 8-diazabicyclo[5.4 .0]undec-7-ene (DBU;4 5mL, 0.30 mmol, 0.25 mol equiv) was added and the reaction was stirred at RT under N 2 overnight. After completion, the mixture was concentrated and the crude was purified by flash chromatography (R f :0 .38 in hexane/EtOAc = 75:25) to yield the pure product as aw hite foam (439 mg, 77 %y ield, exclusively a-product). (124 mg, 0.42 mmol, 1mol equiv) and the donor 9 (200 mg, 0.42 mmol, 1mol equiv) was co-evaporated with toluene three times. Powdered and activated 4 molecular sieves (acid washed) were added. The mixture was kept under vacuum for 3-4 hours and then dissolved in dry CH 2 Cl 2 (10 mL). After cooling to À30 8C, trimethylsilyl trifluoromethanesulfonate (TMSOTf;1 5.2 mL, 0.084 mmol, 0.2 mol equiv) was added to the stirred mixture. The solution was stirred at À30 8Cf or 1hour and upon completion, the reaction was quenched with triethylamine (TEA). The mixture was warmed to room temperature and filtered over aC elite pad. The filtrate was evaporated at reduced pressure and the crude product was purified by flash chromatography (hexane/EtOAc = 72:28) to yield the pure product as aw hite foam (240 mg, 94 %y ield, exclusively a-product). .9 (C 9 ); 174.6 (C 9 ); 170.8 (C=O( AcO));1 70.0 (C=O( AcO));1 69.6 (C=O( AcO));9 5.9 (C 1 ); 75.3 (C C1 ); 71.7 (C C2 ); 71.0 (C 3 ); 69.6 (C 7 ); 69.2 (C 5 ); 66.3 (C 4 ); 62.6 (C 6 ); 61.9 (C 2 ); 52.2 (C 10 ); 43.2 (C 8 ); 39.2 (C C5 ); 39.0 (C C4 ); 28.0, 26.8 (C C3 ,C C6 ); 20.9 (Me (AcO));2 0.8 (Me (AcO));2 0.7 ppm (Me (AcO)); MS (ESI): m/z calculated for [C 24 H 34 General procedure for CuAAC reactions.1m CuSO 4 ·5 H 2 Oa nd Na ascorbate solutions were prepared in degassed water.T he alkyne (1 mol equiv) was dissolved in degassed THF and 0.1 equiv CuSO 4 ·5 H 2 Os olution and 0.4 mol equiv Na ascorbate solutions were added, under nitrogen atmosphere. The azide was also dissolved in degassed THF and added to the mixture. The reaction was stirred under nitrogen, then, upon completion, QuadraSil TM MP metal scavenger was added to remove the copper,t he mixture was filtered and concentrated in vacuo. When the purity of the protected product was satisfactory,t he crude was used directly in the following ZemplØn-deprotection step.
General procedure for ZemplØnd eacetylation:1 mol equiv acetylated compound was dissolved in distilled MeOH and 1 m freshly prepared NaOMe in MeOH was added to the solution (1.5 mol equiv NaOMe) to 0.1 m final concentration of the substrate. After completion, the reaction was neutralized with Amberlite IR120 hydrogen form ion-exchange resin, filtered and concentrated in vacuo. The crude was purified by direct (CH 2 Cl 2 /MeOH) or reversed-phase flash chromatography (water/MeOH/MeCN, for ammonium salts 0.01 %T FA was added), yielding the pure product. Compounds 5a-c, 12 a-c and 16 were isolated as ammonium trifluoroacetate salts. 3.69-3.60 (m, 3H,H 8a,b ,H 4 ), 3.01-2.83 (m, 2H,C 4 ,C 5 ), 2.03-1.89 ppm (m, 4H,C 3 ,C 6 ); 13 CNMR (100 MHz, D 2 O): d = 177.9 (C 9 ); 177.6 (C 9 ); 142.5, 142.4 (C 14 ); 140.7 (C Trq ); 139.8 (C 11 ); 129.3 (C 13 ); 129.2 (C 12 ); 126.8 (C TrCH ); 98.3 (C 1 ); 77.1 (C C1 or C 5 ); 76.7 (C 5 or C C1 ); 73.2 (C C2 ); 71.6 (C 7 ); 71.1 (C 3 ); 69.0 (C 4 ); 65.8 (C 10 ); 65.5 (C 2 ); 63.0 (C 6 ); 45.2 (C 8 ); 44.6, 44.5 (C 15 ); 42.5 (C C4 ,C C5 ); 36. 3 (C 16 
Sample preparation for ITC
ITC experiments were performed at 25 8Cb yu sing aT AI nstrument Nano Isothermal Titration Calorimeter Low Volume (Nano ITC LV) with a1 90 mLc ell volume. Compound 16 and DC-SIGN ECD were prepared in 25 mm Tris-HCl at pH 8, 150 mm NaCl, 4mm CaCl 2 and 4% DMSO. 100 mm of DC-SIGN ECD and 2.5 mm compound concentrations were used. The compound was stepwise injected (1.03 mL) into DC-SIGN solution by using 5min intervals between injections. Ab lank titration (compound to buffer) was done for subtraction of dilution heat from the integrated data. Ao ne-site binding model was fitted to the data (nanoAnalyse 2.20 TA), yielding dissociation constants (K D )and binding enthalpies (DH).
Surface plasmon resonance (SPR) analysis
The extracellular domain (ECD) of DC-SIGN (residues 66-404) was overexpressed and purified as previously described. The SPR experiments were performed on aB IAcore T200 using aC M3 sensor chip. Flow cells were activated as previously described. [18] Flow cell one was functionalized with BSA and blocked with ethanolamine and subsequently used as ac ontrol surface. Flow cells 2a nd 3 were treated with BSA-Mana1-3[Mana1-6]Man (Dextra) (60 mgmL À1 )i n1 0mm NaOAc pH 4t or each different binding densities and blocked with ethanolamine. The final densities on flow cells 2a nd 3w ere 2579 and 2923 RU, respectively.T he affinity of the various compounds for DC-SIGN ECD were evaluated via an established inhibition assay [18] in which DC-SIGN ECD was injected at 20 mm alone or in the presence of increasing concentration of inhibitors (ranging from 0t o5m m). Injections were performed at 5 mLmin À1 using 25 mm Tris-HCl pH 8, 150 mm NaCl, 4mm CaCl 2 , 0,05 %P 20 surfactant as running buffer.T he surface was regenerated by the injection of 50 mm EDTA.
Crystallizationa nd X-ray data collection HTX crystallization platform (EMBL) was used to screen conditions of co-crystallization with the hanging-drop vapor-diffusion method at 293 K. The drop was composed of ap rotein/reservoir ratio of 1:1w ith protein concentrated at 5.54 mg mL À1 in 150 mm NaCl, 4mm CaCl 2 ,2 5mm Tris-HCl pH 8, 2% (v/v)D MSO buffer and 3.25 mm 16.A mong the crystallization hits obtained, the condition F04 (200 mm Mg(NO 3 ) 2 ,2 0% PEG 3350) from the kit PEGs-Suite Qiagen was chosen for manual optimization screening with four different buffers (MES pH 6, HEPES pH 7, Tris pH 8a nd Bicine pH 9), concentration of PEG 3350 (15 %-25 %) and Mg(NO 3 ) 2 concentration (from 150 to 200 mm). Finally,t he best crystals were obtained in the following condition:2 0% PEG 3350, 200 mm Mg(NO 3 ) 2 , 100 mm MES pH 6. Crystals were directly flash frozen in liquid nitrogen using Paratone-N as cryoprotectant. Data collection was performed at id30A-1b eamline (MASSIF-1), ESRF Grenoble, 3200 images were collected at 1008K, with an oscillation range of 0.058,a ne xposure time of 0.039 sp er image, and aw avelength of 0.966 .D ata processing and refinement statistics are described in Ta ble S2 (Supporting Information). Coordinates and associated structure factors have been deposited in the PDB database, code:6GHV.
Analytical ultracentrifugation
Sedimentation velocity experiments were performed in aB eckman XL-I analytical ultracentrifuge with ar otor Anti-50 (Beckman Coulter,P alo Alto, USA) and double-sector cells of optical path length 3 and 1.5 mm equipped of Sapphire windows (Nanolytics, Potsdam, DE). Samples were centrifuged at 42 000 rpm (130 000 g), at 20 8C. Sedimentation velocity profiles were acquired at 280 nm, every 10 min, with a3 0mmr adial step size. DC-SIGN CRD or ECD concentration was fixed at 1.0 mg mL À1 (56 and 26 mm,r espectively), and compound 16 was used at variable concentration of 0, 15.6, 31.25, 62.5, 125, 250 , and 500 mm.S olvent was 25 mm Tris-HCl pH8, 150 mm NaCl, 4mm CaCl 2 ,4m m DMSO (density 1.0055 gmL À1 and viscosity 1.0235 cp, estimated, neglecting DMSO, using the SEDN-TERP software (available free at http://sednterp.unh.edu/). The partial specific volume (v)f or DC-SIGN CRD and DC-SIGN ECD, was estimated from the amino acid compositions as 0.712, and 0.731 mL g À1 ,r espectively,a nd their molar mass (M)a s1 7.7 and 38.8 kDa, by using the SEDFIT software (available free at https:// sedfitsedphat.nibib.nih.gov). Data were analyzed in terms of continuous size distribution c(s) of sedimentation coefficients, s, [19] by using SEDFIT.P eak integration and figures were done with the GUSSI software [20] (http://biophysics.swmed.edu/MBR/software.html). The s and M values were combined in the Svedberg equation to calculate the hydrodynamic radius, R H ,o rf rictional ratio f min (f/f min = R H /R min ,w ith R min the radius of the anhydrous volume) [Eq. (1)]:
for DC-SIGN CRD considered as am onomer, f/f min = 1.4 is derived from the experimental s = 1.8 S, which corresponds to am oderately anisotropic shape. [21] The Svedberg equation was also used to derive corrected in water and at 20 8C s 20w values.
